Literature DB >> 34201847

Cell Death in Coronavirus Infections: Uncovering Its Role during COVID-19.

Annamaria Paolini1, Rebecca Borella1, Sara De Biasi1, Anita Neroni1, Marco Mattioli1, Domenico Lo Tartaro1, Cecilia Simonini1, Laura Franceschini1, Gerolamo Cicco1, Anna Maria Piparo1, Andrea Cossarizza1, Lara Gibellini1.   

Abstract

Cell death mechanisms are crucial to maintain an appropriate environment for the functionality of healthy cells. However, during viral infections, dysregulation of these processes can be present and can participate in the pathogenetic mechanisms of the disease. In this review, we describe some features of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and some immunopathogenic mechanisms characterizing the present coronavirus disease (COVID-19). Lymphopenia and monocytopenia are important contributors to COVID-19 immunopathogenesis. The fine mechanisms underlying these phenomena are still unknown, and several hypotheses have been raised, some of which assign a role to cell death as far as the reduction of specific types of immune cells is concerned. Thus, we discuss three major pathways such as apoptosis, necroptosis, and pyroptosis, and suggest that all of them likely occur simultaneously in COVID-19 patients. We describe that SARS-CoV-2 can have both a direct and an indirect role in inducing cell death. Indeed, on the one hand, cell death can be caused by the virus entry into cells, on the other, the excessive concentration of cytokines and chemokines, a process that is known as a COVID-19-related cytokine storm, exerts deleterious effects on circulating immune cells. However, the overall knowledge of these mechanisms is still scarce and further studies are needed to delineate new therapeutic strategies.

Entities:  

Keywords:  COVID-19; apoptosis; cell death

Mesh:

Substances:

Year:  2021        PMID: 34201847     DOI: 10.3390/cells10071585

Source DB:  PubMed          Journal:  Cells        ISSN: 2073-4409            Impact factor:   6.600


  150 in total

1.  Fas-mediated apoptosis of peripheral blood mononuclear cells in patients with hepatitis C.

Authors:  N Taya; Y Torimoto; M Shindo; K Hirai; C Hasebe; Y Kohgo
Journal:  Br J Haematol       Date:  2000-07       Impact factor: 6.998

2.  Interleukin 18 restores defective Th1 immunity to Candida albicans in caspase 1-deficient mice.

Authors:  A Mencacci; A Bacci; E Cenci; C Montagnoli; S Fiorucci; A Casagrande; R A Flavell; F Bistoni; L Romani
Journal:  Infect Immun       Date:  2000-09       Impact factor: 3.441

3.  Quantitative and qualitative alterations of circulating myeloid cells and plasmacytoid DC in SARS-CoV-2 infection.

Authors:  Benedetta Peruzzi; Sara Bencini; Manuela Capone; Alessio Mazzoni; Laura Maggi; Lorenzo Salvati; Anna Vanni; Chiara Orazzini; Carlo Nozzoli; Alessandro Morettini; Loredana Poggesi; Filippo Pieralli; Adriano Peris; Alessandro Bartoloni; Alessandro Maria Vannucchi; Francesco Liotta; Roberto Caporale; Lorenzo Cosmi; Francesco Annunziato
Journal:  Immunology       Date:  2020-10-06       Impact factor: 7.397

4.  Epstein-Barr virus encoded latent membrane protein 1 suppresses necroptosis through targeting RIPK1/3 ubiquitination.

Authors:  Xiaolan Liu; Yueshuo Li; Songling Peng; Xinfang Yu; Wei Li; Feng Shi; Xiangjian Luo; Min Tang; Zheqiong Tan; A M Bode; Ya Cao
Journal:  Cell Death Dis       Date:  2018-01-19       Impact factor: 8.469

5.  A pneumonia outbreak associated with a new coronavirus of probable bat origin.

Authors:  Peng Zhou; Xing-Lou Yang; Xian-Guang Wang; Ben Hu; Lei Zhang; Wei Zhang; Hao-Rui Si; Yan Zhu; Bei Li; Chao-Lin Huang; Hui-Dong Chen; Jing Chen; Yun Luo; Hua Guo; Ren-Di Jiang; Mei-Qin Liu; Ying Chen; Xu-Rui Shen; Xi Wang; Xiao-Shuang Zheng; Kai Zhao; Quan-Jiao Chen; Fei Deng; Lin-Lin Liu; Bing Yan; Fa-Xian Zhan; Yan-Yi Wang; Geng-Fu Xiao; Zheng-Li Shi
Journal:  Nature       Date:  2020-02-03       Impact factor: 69.504

6.  Circulating mucosal-associated invariant T cells identify patients responding to anti-PD-1 therapy.

Authors:  Sara De Biasi; Lara Gibellini; Domenico Lo Tartaro; Simone Puccio; Claudio Rabacchi; Emilia M C Mazza; Jolanda Brummelman; Brandon Williams; Kelly Kaihara; Mattia Forcato; Silvio Bicciato; Marcello Pinti; Roberta Depenni; Roberto Sabbatini; Caterina Longo; Massimo Dominici; Giovanni Pellacani; Enrico Lugli; Andrea Cossarizza
Journal:  Nat Commun       Date:  2021-03-15       Impact factor: 14.919

Review 7.  Necrostatin-1 and necroptosis inhibition: Pathophysiology and therapeutic implications.

Authors:  Liyuan Cao; Wei Mu
Journal:  Pharmacol Res       Date:  2020-11-09       Impact factor: 7.658

8.  A single-cell atlas of the peripheral immune response in patients with severe COVID-19.

Authors:  Aaron J Wilk; Arjun Rustagi; Nancy Q Zhao; Jonasel Roque; Giovanny J Martínez-Colón; Julia L McKechnie; Geoffrey T Ivison; Thanmayi Ranganath; Rosemary Vergara; Taylor Hollis; Laura J Simpson; Philip Grant; Aruna Subramanian; Angela J Rogers; Catherine A Blish
Journal:  Nat Med       Date:  2020-06-08       Impact factor: 53.440

Review 9.  Natural history of COVID-19 and current knowledge on treatment therapeutic options.

Authors:  Wagner Gouvea Dos Santos
Journal:  Biomed Pharmacother       Date:  2020-07-03       Impact factor: 6.529

Review 10.  Coronaviruses: Innate Immunity, Inflammasome Activation, Inflammatory Cell Death, and Cytokines.

Authors:  SangJoon Lee; Rudragouda Channappanavar; Thirumala-Devi Kanneganti
Journal:  Trends Immunol       Date:  2020-10-15       Impact factor: 16.687

View more
  13 in total

Review 1.  Revisiting Regulated Cell Death Responses in Viral Infections.

Authors:  Devasahayam Arokia Balaya Rex; Thottethodi Subrahmanya Keshava Prasad; Richard K Kandasamy
Journal:  Int J Mol Sci       Date:  2022-06-24       Impact factor: 6.208

2.  Molecular and cellular immune features of aged patients with severe COVID-19 pneumonia.

Authors:  Domenico Lo Tartaro; Anita Neroni; Annamaria Paolini; Rebecca Borella; Marco Mattioli; Lucia Fidanza; Andrew Quong; Carlene Petes; Geneve Awong; Samuel Douglas; Dongxia Lin; Jordan Nieto; Licia Gozzi; Erica Franceschini; Stefano Busani; Milena Nasi; Anna Vittoria Mattioli; Tommaso Trenti; Marianna Meschiari; Giovanni Guaraldi; Massimo Girardis; Cristina Mussini; Lara Gibellini; Andrea Cossarizza; Sara De Biasi
Journal:  Commun Biol       Date:  2022-06-16

Review 3.  A comprehensive review about immune responses and exhaustion during coronavirus disease (COVID-19).

Authors:  Rebar N Mohammed; Rozita Tamjidifar; Heshu Sulaiman Rahman; Ali Adili; Shadi Ghoreishizadeh; Hossein Saeedi; Lakshmi Thangavelu; Navid Shomali; Ramin Aslaminabad; Faroogh Marofi; Mina Tahavvori; Svetlana Danshina; Morteza Akbari; Gülinnaz Ercan
Journal:  Cell Commun Signal       Date:  2022-06-02       Impact factor: 7.525

4.  COVID-19 mortality is associated with pre-existing impaired innate immunity in health conditions.

Authors:  Matthew Lee; Yung Chang; Navid Ahmadinejad; Crista Johnson-Agbakwu; Celeste Bailey; Li Liu
Journal:  PeerJ       Date:  2022-05-06       Impact factor: 3.061

Review 5.  Pattern Recognition Proteins: First Line of Defense Against Coronaviruses.

Authors:  Carlos A Labarrere; Ghassan S Kassab
Journal:  Front Immunol       Date:  2021-09-23       Impact factor: 7.561

6.  Plasma Cytokine Atlas Reveals the Importance of TH2 Polarization and Interferons in Predicting COVID-19 Severity and Survival.

Authors:  Lara Gibellini; Sara De Biasi; Marianna Meschiari; Licia Gozzi; Annamaria Paolini; Rebecca Borella; Marco Mattioli; Domenico Lo Tartaro; Lucia Fidanza; Anita Neroni; Stefano Busani; Massimo Girardis; Giovanni Guaraldi; Cristina Mussini; Alessandro Cozzi-Lepri; Andrea Cossarizza
Journal:  Front Immunol       Date:  2022-03-21       Impact factor: 7.561

7.  Necroptosis Contributes to Persistent Inflammation During Acute Leptospirosis.

Authors:  Suman Kundu; Advait Shetty; Maria Gomes-Solecki
Journal:  Front Immunol       Date:  2022-03-22       Impact factor: 7.561

8.  ACE2 overexpressing mesenchymal stem cells alleviates COVID-19 lung injury by inhibiting pyroptosis.

Authors:  Jinhuan Wei; Rui Shang; Jiaqi Wang; Shengze Zhu; JianQiang Yin; Ying Chen; Yayu Zhao; Gang Chen
Journal:  iScience       Date:  2022-03-10

9.  T cell perturbations persist for at least 6 months following hospitalization for COVID-19.

Authors:  Melissa Govender; Francis R Hopkins; Robin Göransson; Cecilia Svanberg; Esaki M Shankar; Maria Hjorth; Åsa Nilsdotter-Augustinsson; Johanna Sjöwall; Sofia Nyström; Marie Larsson
Journal:  Front Immunol       Date:  2022-08-08       Impact factor: 8.786

10.  Co-Regulation of Protein Coding Genes by Transcription Factor and Long Non-Coding RNA in SARS-CoV-2 Infected Cells: An In Silico Analysis.

Authors:  Chinmay Saha; Sayantan Laha; Raghunath Chatterjee; Nitai P Bhattacharyya
Journal:  Noncoding RNA       Date:  2021-11-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.